PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN

被引:371
作者
KUPFER, A
PREISIG, R
机构
关键词
D O I
10.1007/BF00541938
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:753 / 759
页数:7
相关论文
共 35 条
[1]   ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J].
ALDABBAGH, SG ;
IDLE, JR ;
SMITH, RL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) :161-164
[2]   PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].
BERTILSSON, L ;
DENGLER, HJ ;
EICHELBAUM, M ;
SCHULZ, HU .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155
[3]  
BUTLER TC, 1952, J PHARMACOL EXP THER, V104, P299
[4]  
BUTLER TC, 1956, J PHARMACOL EXP THER, V117, P160
[5]   IMPAIRMENT OF PHENYTOIN PARA-HYDROXYLATION AS A CAUSE OF SEVERE INTOXICATION [J].
DEWOLFF, FA ;
VERMEIJ, P ;
FERRARI, MD ;
BURUMA, OJS ;
BREIMER, DD .
THERAPEUTIC DRUG MONITORING, 1983, 5 (02) :213-215
[6]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[7]   POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J ;
ZEKORN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186
[8]  
EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[9]   ACUTE INTOXICATION WITH 5,5-DIPHENYLHYDANTOIN (DILANTIN) ASSOCIATED WITH IMPAIRMENT OF BIOTRANSFORMATION - PLASMA LEVELS AND URINARY METABOLITES - STUDIES IN HEALTHY VOLUNTEERS [J].
GERBER, N ;
LYNN, R ;
OATES, J .
ANNALS OF INTERNAL MEDICINE, 1972, 77 (05) :765-+
[10]   POLYMORPHISMS OF OXIDATION AT CARBON CENTERS OF DRUGS AND THEIR CLINICAL SIGNIFICANCE [J].
IDLE, JR ;
SMITH, RL .
DRUG METABOLISM REVIEWS, 1979, 9 (02) :301-317